AMGN: Amgen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 125,808.65
Enterprise Value ($M) 154,462.65
Book Value ($M) 14,909.00
Book Value / Share 22.97
Price / Book 8.44
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.07

Liquidity (mrq)
Quick Ratio 3.12
Current Ratio 3.39

Balance Sheet (mrq) ($M)
Current Assets 37,970.00
Assets 67,684.00
Liabilities 52,775.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22,849.00
Operating Income 9,973.00
Net Income 1,979.00
Earnings Per Share Diluted 2.69
Earnings Per Share Basic 2.71

Cash Flow Statement (mra) ($M)
Cash From Operations 11,177.00
Cash from Investing -4,024.00
Cash from Financing -4,024.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2018-02-13 13G/A FMR LLC / Fidelity 7.15 27.20
2018-02-13 13G/A Capital Research Global Investors 7.00 -22.23
2018-02-12 13G/A Vanguard Group Inc 7.20 8.81
2018-01-29 13G/A BlackRock Inc. 6.80 -2.08

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2018-07-27 10-Q AMGN / Amgen Inc. 10-Q (Quarterly Report)
2018-04-25 10-Q AMGN / Amgen Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ALXN – Alexion Pharmaceuticals, Inc. AMAG – AMAG Pharmaceuticals, Inc.
AMBI – Ambit Biosciences Corp AMPH – Amphastar Pharmaceuticals, Inc.
AMRN – Amarin Corp. Plc


Financial data and stock pages provided for FREE by
Fintel.io